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Abstract
T lymphoma invasion and metastasis 1 (Tiam1) is a
metastasis-related gene of T lymphoma that is also in-
volved in themetastasis of a variety of other cancers. In
this study, we tested the hypothesis that Tiam1 is a de-
terminant of proliferation and metastasis in colorectal
cancer, and we examined the effect of the inhibition of
Tiam1 expression on proliferation and metastasis. We
succeeded in establishing the Tiam1 knockdown colo-
rectal cancer cell line using human immunodeficiency
virus lentivirus-mediated RNA interference (RNAi) and
found that the silencing of Tiam1 resulted in the effec-
tive inhibition of in vitro cell growth and of the invasive
ability of colorectal cancer cells. Using an orthotopic
xenograft model in nudemice, we confirmed that Tiam1
silencing could reduce tumor growth by subcutaneous
injection and could suppress lung and liver metastases
of colorectal cancer cells. Our results suggest that
Tiam1 truly plays a causal role in the metastasis of
colorectal cancer and that RNAi-mediated silencing of
Tiam1 may provide an opportunity to develop a new
treatment strategy for colorectal cancer.
Neoplasia (2006) 8, 917–924
Keywords: Tiam1 gene, RNA interference, colorectal cancer, proliferation,
metastasis.
Introduction
Small guanosine triphosphate (GTP)–binding proteins of the
Ras superfamily function as molecular switches in funda-
mental events such as signal transduction, cytoskeleton
dynamics, and intracellular trafficking [1,2]. Mutations or
aberrant regulation of these proteins can contribute to malig-
nant phenotypes of human tumors. Guanine nucleotide ex-
change factors (GEFs), which catalyze the dissociation of
guanosine diphosphate from inactive GTP-binding proteins,
positively regulate these GTP-binding proteins in response
to a variety of signals. Currently, manyGEFs, includingVav1,
LARG, Bcr, and T lymphoma invasion and metastasis 1
(Tiam1), have been identified as oncogenes [3–6].
Tiam1 was originally identified as an invasion-inducing
and metastasis-inducing gene by proviral tagging, in com-
bination with in vitro selection for invasiveness in T lym-
phoma cells [7]. The role of Tiam1 in cellular migration,
invasion, and metastasis may not be limited to T lymphoma. It
has been reported to be important in promoting tumor progres-
sion in a variety of cancers, such as breast cancer, colorectal
cancer, lung cancer, and Ras-induced skin tumors [8–11].
In our previous studies, to screen metastasis-associated
genes, we prepared a cDNA microarray of tumor metastasis–
associated genes and obtained 51 genes that were closely
associated with metastases of colorectal cancer [12,13]. Mining
microarray gene expression data by literature profiling, we
found that Tiam1 had potential relation to metastatic colorectal
cancer [14]. To further investigate the effect of Tiam1 on me-
tastases of colorectal cancer, we detected Tiam1 expression in
cell lines and in different tissue specimens of colorectal cancer.
We found that Tiam1 expression was highly related to meta-
static potential in colorectal cancer and that Tiam1 was a
metastasis-related gene [15]. However, it is unclear whether
the knockdown of Tiam1 is responsible for metastatic pheno-
types in colorectal cancer, and its mechanism is unclear as well.
In this study, we established a stable Tiam1 silencing colo-
rectal cancer cell line with lentiviral vector–mediated RNA
interference (RNAi) technology and determined whether Tiam1
silencing could influence in vitro proliferation and invasion and
in vivo tumor growth and metastasis.
Materials and Methods
Cell Line and Animals
The human colorectal cancer cell line SW480/EGFP was
established from SW480 by transfection of pEGFP-N1 plasmid
and was cultured in RPMI 1640 medium (Gibco, Grand Island,
NY) supplemented with 10% fetal bovine serum (FBS) and
100 U/ml penicillin/streptomycin in a 5% CO2 humidified atmo-
sphere at 37jC. The 293FT cell line, which stably expresses
SV40 large T antigen and facilitates the optimal production
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of viruses, was cultured in Dulbecco’s modified Eagle’s
medium (Gibco).
Four- to 6-week-old female/male athymic BALB/c nu/nu
mice were purchased from the Central Laboratory of Animal
Science at Southern University (Guangzhou, China) and
maintained in laminar-flow cabinets under specific pathogen-
free conditions.
Preparation of Lentiviral Vectors
Firstly, we selected four different sequences for targeting
the Tiam1 gene using the BLOCK-It RNAi Designer (Invi-
trogen, Carlsbad, CA) (http://rnaidesigner.invitrogen.com/
rnaiexpress/rnaiExpress.jsp) (Table 1). The preparation of
lentiviral vectors expressing human Tiam1 short hairpin RNA
(shRNA) was performed using the BLOCK-It Lentiviral RNAi
Expression System (catalog no. K4944-00; Invitrogen), fol-
lowing the manufacturer’s instruction. In brief, four pLenti6/
Tiam1 expression vectors containing the human Tiam1
shRNA-expressing cassette were constructed. Replication-
incompetent lentivirus was produced by cotransfection of the
pLenti6/Tiam1 expression vector and ViraPower packaging
mix (Invitrogen) containing an optimized mixture of three
packaging plasmids: pLP1, pLP2, and pLP/VSVG) into
293FT cells. RNA; expression system includes ViraPower
packaging mix. Viral supernatant was harvested 48 hours
after transfection, filtered through a 0.45-mm cellulose ace-
tate filter, and frozen at 70jC. The lentivirus containing
the human Lamin A/C shRNA-expressing cassette (sequence
5V-CTGGACTTCCAGAAGAACA-3V) was used as a positive
control for lentivirus production, and the lentivirus-only–
containing pLenti6/U6 mock vector was used as negative
control. Viral concentrations were determined by in vitro
transduction and blasticidin selection.
Construction of Stable Silencing Lines
SW480/EGFP cells were transduced with specific or
negative control lentiviral vectors and selected for stable
integrants by culturing a complete medium containing blasti-
cidin. After 12 days of selection, there were no viable cells in
mock wells and discrete blasticidin resistance colonies.
Real-Time Reverse Transcription Polymerase Chain
Reaction (PCR) Analysis for Tiam1
cDNA was synthesized by oligo dT primed reverse tran-
scription from 2 mg of total RNA using an access reverse
transcription system (Promega, Madison, WI). Real-time PCR
was performed using Mx3000P Real-Time PCR System
(Stratagene, La Jolla, CA) and Brilliant SYBR Green QPCR
Master Mix kit (Stratagene), following the manufacturer’s
protocol. In brief, the reaction mixture (total volume, 25 ml)
contained 500 ng of cDNA, the forward primer 5V-AAGACG-
TACTCAGGCCATGTCC-3V, and the reverse primer 5V-
GACCCAAATGTCGCAGTCAG-3V to amplify human Tiam1
(GeneBank, NM_003253) at a final concentration of 250 nM
and with 12.5 ml of 2 SYBR Green QPCR Master Mix kit.
Thermal cycling conditions were as follows: 95jC for 5 min-
utes and 45 cycles at 95jC for 40 seconds, followed by 58jC
for 40 seconds and 72jC for 40 seconds. Experiments were
performed in triplicate in the same reaction. Human b-actin
gene was amplified as internal control. Target genes and b-
actin gene were amplified in the same reaction. Comparative
quantification is determined using the 2DDCt method [16].
Western Blot Analysis
Cells were washed twice with cold phosphate-buffered
saline (PBS) and lysed on ice in RIPA buffer [1 PBS, 1%
NP40, 0.1% sodium dodecyl sulfate (SDS), 5mMEDTA, 0.5%
sodium deoxycholate, and 1 mM sodium orthovanadate] with
protease inhibitors. Protein lysates were resolved on 6% SDS
polyacrylamide gel, electrotransferred to polyvinylidene fluo-
ride membranes (Immobilon P; Millipore, Bedford, MA), and
blocked in 5% nonfat dry milk in Tris-buffered saline, pH 7.5
(100mMNaCl, 50mMTris, and 0.1%Tween-20). Membranes
were immunoblotted overnight at 4jC with anti-Tiam1 poly-
clonal antibody (Santa Cruz Biotechnology, Santa Cruz, CA),
anti–Lamin A/C antibody (Chemicon, Temecula, CA), and
anti–b-actin antibody (Santa Cruz Biotechnology), followed
by their respective horseradish peroxidase–conjugated sec-
ondary antibodies. Signalswere detected by enhanced chemi-
luminescence (Pierce, Rockford, IL).
In Vitro Cell Growth Assay
The cells were prepared at a concentration of 1104 cells/
ml, respectively. Aliquots (100 ml) were dispensed into 96-well
microtiter plates. The cells were incubated for 1, 2, 3, 4, 5, 6,
and 7 days, respectively, and 3-(4,5-dimethylthiazol-2-yl)-
2,5-diphenyltetrazolium bromide (MTT) assay was per-
formed by adding 20 ml of MTT (5 mg/ml; Promega) for
4 hours. When MTT incubation had been completed, super-
natants were removed. One hundred fifty milliliters of di-
methyl sulfoxide (Sigma, St. Louis, MO) was added to each
well. Fifteen minutes later, the absorbance value (OD) of
each well was measured with a microplate reader set at
570 nm. All experiments were performed in triplicate.
Plate Clone Formation Assay
About 1  102 cells were added to each well (3 cm in
diameter) of a six-well culture plate, and each cell group con-
tained three wells. After incubation at 37jC for 12 days, the
cells were washed twice with PBS and stained with Giemsa
solution. The number of colonies containing z 50 cells was
counted under amicroscope [plate clone formation efficiency =
(number of colonies / number of cells inoculated)  100%].
Flow Cytometry Analysis for Cell Cycle
Cells were harvested at an exponential growth phase, and
single-cell suspensions containing 1  106 cells were fixed
with 70% alcohol. Cell cycle was monitored using propidium
Table 1. Targeted Sequences of Tiam1 Gene for RNAi.
Site Start Target sequence
A 920 5V- GCATTCCTATACATCCAATGG-3V
B 2223 5V- GGTGAAATGCAGCTGTCTTCA-3V
C 3631 5V- GCACCTACGTGAAGGATTTAA-3V
D 4368 5V- GCTGTGGTCCTTGTGTATAAA-3V
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iodide (PI) staining of nuclei. The fluorescence of DNA-bound
PI in cells was measured with a FACScan flow cytometer (BD
Biosciences), and the results were analyzed with ModFit 3.0
software (Verity Software House, Topsham, ME).
In Vitro Invasion Assay
This assay was performed using themethod of Albini et al.
[17], with modifications. The cell invasion chamber (Chemi-
con) contains a polycarbonate membrane with an 8-mm pore
size, over which a thin layer of ECMatrix (Chemicon) is dried.
The extracellular matrix (ECM) layer occludes membrane
pores, blocking noninvasive cells from migrating. To the top
chamber was added warm serum-free medium to rehydrate
the ECM layer for 2 hours at room temperature. Tumor cells in
a serum-free medium (300 ml containing 1  105 cells) were
added to the top chamber. The bottom chamber was pre-
pared using 10% FBS as chemoattactant. After 24 hours of
incubation, noninvasive cells were removed with a cotton
swab. The cells that hadmigrated through themembrane and
had stuck to the lower surface of the membrane were fixed
with methanol and stained with hematoxylin. For quantifica-
tion, the cells were counted under a microscope in five
predetermined fields (original magnification, 200).
In Vivo Tumor Growth Assay
To evaluate in vivo tumor growth, 1  107 Tiam1 silencing
cells and mock virus-transduced cells were each injected
subcutaneously into the left flank and right flank of six nude
mice. After subcutaneous injection of cells, fluorescence
emitted by cells was collected and imaged through a whole-
body green fluorescence protein (GFP) imaging system
(Lighttools, Encinitas, CA). Using IPP5.0 software (Cyber-
metics Co., Silver Spring, MD), images were analyzed such
that whole-body optical images visualized real-time tumor
growth and tumor area was calculated.
In Vivo Metastasis Assays
The cells were first harvested by trypsinization, washed
thrice with cold serum-free medium, and resuspended with
serum-free medium. Nude mice were injected subcutaneously
with 1  107 cells. After 10 days, the tumors were extirpated
and washed twice with antibiotic-containing RPMI 1640 me-
dium. Cancerous tissue was divided into small pieces, ap-
proximately 1 mm in diameter. Nude mice were anesthetized
with Nembutal (Sinopharm Chemical Reagent Co., Shanghai,
China) and sterilized with alcohol. For colon surgical orthotopic
implantation (SOI) using the method described previously
[18], a small midline incision was made, and the colocecal part
of the intestine was exteriorized. A small area of the colonal
serosa was removed, and a 1-mm3 tumor fragment per mouse
was implanted. A 7-0 nylon surgical suture was used to pene-
trate tumor pieces and to suture them to the intestine wall. The
intestine was returned to the abdominal cavity, and the ab-
dominal wall was closed with a 6-0 silk surgical suture. Whole-
body optical images visualized real-time primary tumor growth
and the formation of metastatic lesions. Two months later, all
mice were killed, individual organs were excised, and metas-
tases were checked by hematoxylin–eosin (H&E) staining.
Statistical Analysis
SPSS 12.0 software (Abbott Laboratories, North Chicago,
IL) was used for statistical analysis. Assay differences be-
tween in vitro cell growth and in vivo tumor growthwere tested
for statistical significance using analysis of variance (ANOVA)
for factorial design. Plate clone formation assay and in vitro
invasion assay were tested using one-way ANOVA. Differ-
ences were considered statistically significant when P < .05.
Results
Establishment of Tiam1 Silencing Colorectal Cancer
Cell Line
To deliver siRNA into the SW480/EGFP colorectal cancer
cell line, we developed four lentiviral-based vectors that
express different shRNA. After the cotransfection of pLenti6/
Tiam1 vector and ViraPower packaging mix, replication-
incompetent lentivirus was released into the medium and
collected 48 hours after transfection. Viral stocks were tittered
on SW480/EGFP cells, and 7 105 transducing units (TU)/ml
was obtained (Figure 1).
SW480/EGFP cells were transduced with pLenti6/U6,
pLenti6/Tiam1, and pLenti6/Lamin A/C viral stocks and were
selected by blasticidin 48 hours after transduction. Ten days
posttransduction, cells were analyzed for Lamin A/C and
Tiam1 expression using real-time PCR and Western blot
analysis. As shown in Figure 2, site B lentiviral vector was
most effective at blocking Tiam1 expression. There was no
difference in cell morphology. Subsequently, we transduced
pLenti6/Tiam1 (site B) and pLenti6/U6 lentiviruses into
SW480/EGFP cells to select blasticidin-resistant single
clones. Transduced clones were expanded and examined
by real-time PCR and Western blot analysis (Figure 3).
Results showed that Tiam1 knockdown clone 2 (Tiam1KD/
clone 2), knockdown clone 8 (Tiam1KD/clone 8), and knock-
down clone 6 (Tiam1KD/clone 6) exhibited 88%, 80%, and
Figure 1. Titering lentiviral stock. Cells were either transduced with 10-fold
serial dilutions of lentiviral supernatant (102–106 dilutions) or untransduced
(Mock cells). Forty-eight hours posttransduction, the cells were placed under
blasticidin selection. After 14 days of selection, the cells were stained with
crystal violet, and colonies were counted. The virus titer was 7  105 TU/ml.
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66% reduction in Tiam1 protein, respectively. The clone
transduced by pLenti6/U6 lentivirus exhibited no change in
Tiam1 expression. For the sake of convenience, the SW480/
EGFP cells and the clone transduced by pLenti6/U6 lentivirus
are termed WTand Mock cells.
Tiam1 Gene Silencing Suppresses Cell Proliferation In Vitro
The effect of Tiam1 protein reduction on the proliferation of
colorectal cancer cells was determined by MTT assay and
plate clone formation assay. As shown in Figure 4A, although
Mock cells showed in vitro growth ability approximating that
of WT cells, Tiam1KD/clone 6 had reduced growth ability
with respect to Mock cells, Tiam1KD/clone 8 had reduced
growth ability with respect to Tiam1KD/clone 6, and
Tiam1KD/clone 2 had reduced growth ability with respect to
Tiam1KD/clone 8. Therefore, in vitro cell growth ability corre-
lates with Tiam1 expression.
The ability of cells to form colonies in plates was examined
because there exists a correlation between clonogenicity and
metastatic propensity. Figure 4B shows that Tiam1 knock-
down cells, compared with WTand Mock cells, had a signifi-
cant reduction in their ability to form colonies, and their ability
to form colonies correlates with Tiam1 expression.
Flow Cytometry Analysis for Cell Cycle
In Figure 5, cell cycle analysis by flow cytometry reveals
that the proportion of cells in the G0/G1, S, and G2/M phases
Figure 2. Screening of the most effective targeting site for the Tiam1 gene by
real-time PCR and Western blot analysis. (A) Quantification of Tiam1 mRNA
expression in cells of different interference sites relative to controls (M, pLenti6/
U6 Mock virus-transduced cells), as detected by real-time PCR. (B) Tiam1
protein expression in cells of different interference sites, as detected by
Western blot analysis. Lane L shows that a greater degree of Lamin A/C
knockdown was observed after transduction with a lentivirus containing the
human Lamin A/C shRNA-expressing cassette. Lane B shows that lentiviral
vectors were effective and that site B was the most effective construct.
Figure 3. Confirmation of Tiam1 expression in different clones by real-time
PCR and Western blot analysis. (A) Quantification of Tiam1 mRNA
expression in clones transduced by the pLenti6/Tiam1 (site B) lentivirus
relative to controls (clone transduced by pLenti6/U6 lentivirus). (B) Western
blot analysis shows marked reduction of Tiam1 protein expression in clones 2
and 8. Lane 1, SW480/EGFP cells; lane 2, pLenti6/Tiam1 lentivirus–
transduced clone 2; lane 3, pLenti6/Tiam1 lentivirus– transduced clone 8;
lane 4, pLenti6/Tiam1 lentivirus– transduced clone 4; lane 5, pLenti6/U6
lentivirus– transduced clone.
Figure 4. Tiam1 gene silencing suppresses cell proliferation in vitro. (A) The
in vitro proliferative abilities of WT cells, Mock cells, Tiam1KD/clone 2,
Tiam1KD/clone 6, and Tiam1KD/clone 8 cells were evaluated by MTT assay.
Each value represents the mean ± SD of the absorbance value (OD). Results
showed that all Tiam1 knockdown cells grew significantly more slowly thanWT
andMock cells, and Tiam1 protein expression correlated with cell proliferation.
(B) The plate colony formation efficiency of WT cells, Mock cells, Tiam1KD/
clone 2, Tiam1KD/clone 6, and Tiam1KD/clone 8 cells. Data represent the
mean ± SD of triplicate dishes. Compared with WT and Mock cells, Tiam1KD/
clone 2 had significantly reduced ability for colony formation (P < .01), and
Tiam1KD/clone 8 also showed decreased clonogenicity (P < .05). Tiam1KD/
clone 6, compared with WT and Mock cells, displayed no difference in
clonogenicity (P > .05). Results showed that plate colony formation efficiency
also correlated with Tiam1 protein expression.
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forWTcells, Mock cells, Tiam1KD/clone 2, Tiam1KD/clone 6,
and Tiam1KD/clone 8 cells were significantly different. The
proportion of G0 to G1 phase was highest in Tiam1KD/
clone 2, whereas the proportion of S phase was lowest in
Tiam1KD/clone 2.
Tiam1 Gene Silencing Suppresses Cell Invasion In Vitro
Invasion through the ECM is an important step in tumor
metastasis. ECMatrix serves as a reconstituted basement
membrane matrix of proteins. The number of cells migrat-
ing to ECMatrix was counted. Tiam1 knockdown cells,
compared with WT and Mock cells, display a remarkable
decrease in invasiveness (P < .01). As shown in Figure 6,
Tiam1KD/clone 2, Tiam1KD/clone 8, and Tiam1KD/clone 6
displayed a 1.72-fold, 1.44-fold, and 1.20-fold decrease in
invasive ability, respectively, compared with WTcells. These
results demonstrate that the invasive ability of colorectal
cancer cells correlated with Tiam1 expression, and Tiam1
silencing alone is sufficient to attenuate invasion in colorectal
cancer cells.
Figure 5. Effect of Tiam1 knockdown on the cell cycle detected by flow cytometry analysis. Tiam1 silencing cells showed G0 /G1 phase arrest and G2/M and S
phase reduction. The difference was statistically significant.
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Tiam1 Gene Silencing Suppresses Cell Proliferation In Vivo
The effect of Tiam1 on in vivo tumor growth was assessed
by the subcutaneous injection of Tiam1KD/clone 2 and Mock
cells for 30 days. External fluorescent images can provide
invaluable real-time data for tracking tumor growth. As shown
in Figure 7, compared with that of Mock cells, the knock-
down of Tiam1 expression progressed from a pronounced
decrease in Tiam1KD/clone 2 cell growth by day 15 to a 1.3-
fold decrease in tumor area by day 30 after cell injection.
Tiam1 Silencing Reduces Metastatic Tumor Formation
To unambiguously elucidate the effect of Tiam1 on colo-
rectal cancer metastasis, we performed in vivo metastasis
assay by SOI. Mice were sacrificed 2 months later because
the mice of the Mock group were moribund. Autopsy was
performed, and the incidence of metastasis in the liver, lungs,
and other organs was determined by macroscopic and his-
tologic examinations (Figure 8). In the Mock group, 75% (six
of eight) of mice developed peritoneal metastasis, which
appeared as numerous bright green fluorescence on the
peritoneum and on abdominal organs under a GFP imaging
system. A comparison of external fluorescent images was
made, and the results showed a direct image of mice and a
external fluorescent image closelymatching the direct image.
In addition, the Tiam1KD/clone 2 in the orthotopical cecum
ofmice seldomexpressed Tiam1 protein, whereasMock cells
in the orthotopical cecum ofmouse stained positive for Tiam1
(Figure W1). In the Tiam1KD/clone 2 group, only 37.5%
(three of eight) of animals had peritoneal metastasis. The
incidence of hepatic metastasis and lung lesions in mice of
theMock group was 37.5% (three of eight) and 12.5% (one of
eight), respectively, and metastatic lesions were validated by
pathological methods. The Tiam1KD/clone 2 group did not
produce detectable tumors in the liver and other organs.
Figure 6. Effect of Tiam1 knockdown on the invasive potential of colorectal
cancer cells. In vitro invasion assay was carried out to compare and quantify
the invasiveness of WT cells, Mock cells, Tiam1KD/clone 2, Tiam1KD/clone 6,
and Tiam1KD/clone 8. Results are representative of three independent ex-
periments, and bars represent the mean ± SD. Tiam1 silencing cells showed
decreased invasion that correlated with Tiam1 protein expression.
Figure 7. Tiam1 gene silencing suppresses cell proliferation in vivo. (A) Consecutive external whole-body fluorescence images of Mock cells and Tiam1KD/clone 2
tumors were obtained from days 2 to 30 after subcutaneous injection into nude mice. (B) Tumor areas were calculated by IPP5.0 software and were indicated as
the mean ± SD of six mice. Compared with Mock cells, Tiam1KD/clone 2 had a significantly reduced in vivo proliferative ability (F = 2.256, P < .05).
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These results indicate that Tiam1 silencing was sufficient
to decrease metastasis in colorectal cancer cells.
Discussion
RNAi describes the phenomenon by which double-stranded
RNA induces potent and specific inhibition of eukaryotic gene
expression through the degradation of complementary mes-
senger RNA (mRNA) and is functionally similar to the pro-
cesses of posttranscriptional gene silencing. In the past few
years, siRNA and shRNA have been widely used by
researchers to silence the expression of many target genes
because of their high specificity and apparent nontoxicity
[19,20]. Furthermore, systems based on lentiviral vectors
have provided new solutions to achieving stable shRNA-
mediated knockdown [21,22].
In the present study, we used a lentivirus-mediated RNAi
method to obtain an efficient knockdown of Tiam1 gene.
Overexpression of Tiam1 seems to play a critical role inmany
human cancers. Recent results from other laboratories [9]
and ours have demonstrated that increased Tiam1 expres-
sion correlates with the metastatic potential of human colo-
rectal cancer and that Tiam1 was upregulated in the
intestines of adenomatous polyposis coli (APC) conditional
mutant mice [23]. In Tiam1/ mice, susceptibility to the de-
velopment of Ras-induced skin tumors, following application
of a chemical carcinogenesis protocol, was significantly
reduced [11]. This suggests that Tiam1 is a significant mod-
ulator of tumor development and metastasis, thus a poten-
tially interesting therapeutic target.
In this study, we found thatTiam1was one of the colorectal
cancer genes associated with proliferation. The proliferation
ability of tumor cells always correlates with metastatic pheno-
type and poor outcome [24]. We found that knockdown of
Tiam1 expression strongly inhibited in vitro cell growth and
colony formation efficiency. Moreover, through whole-body
optical imaging that enables a continuous visual monitoring of
malignant growth within intact animals, we found that silenc-
ing of Tiam1 expression appeared to have an inverse corre-
lation with tumorigenicity. All data indicated that Tiam1 may
be a positive regulator of tumor growth in colorectal cancer.
In agreement with Minard [9], our experiments demon-
strated that knockdown of Tiam1 expression in colorectal
cancer cells reduced their ability to invade ECMatrix-coated
membranes in an invasion chamber assay. These results
support the involvement of Tiam1 with the malignant be-
havior of human colorectal cancer cells and underline the
relevance of a stable lentivirus-based Tiam1 knockdown
Figure 8. Tiam1 silencing reduces metastatic lesions in vivo. We assessed the effect of Tiam1 silencing on metastasis using an orthotopic xenograft model in nude
mice. After 2 months, the colon, lungs, and liver of mice were resected and analyzed for metastasis. Left panel: Direct image of colon, lungs, and liver. Middle
panel: External fluorescent image of colon, lungs, and liver. Right panel: Histologic photomicrographs of colon, lung, and liver tissue sections stained with H&E
(original magnification, 400).
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mediated by RNAi in the impairment of the invasive ability of
colorectal cancer.
Tiam1 has been extensively studied for the exchange
factor’s role in cellular migration, adhesion, and invasion.
However, limited information on the promotion of in vivo
metastasis is available. Our results demonstrated clearly that
downregulated Tiam1 expression in colorectal cancer cells
significantly suppressed the metastatic potential in Tiam1
silencing cells. We checked Tiam1 expression levels in
Tiam1 knockdown clone before each experiment to ensure
that Tiam1 expression was consistently of low level. We used
an orthotopic xenograft model to evaluate the effect of Tiam1
silencing on metastasis because the models developed with
SOI can exhibit patient-like metastasis. The reduced ex-
pression of Tiam1 in SW480/EGFP cells abrogated their
ability to develop lung and hepatic metastases.
Taken together, our results indicate that the silencing of
Tiam1 expression by RNAi suppressed the proliferation of
colorectal cancer both in vitro and in vivo. This is the first
study to demonstrate that targeting Tiam1 in vivo reduced the
metastatic potential of colorectal cancer. Tiam1 is an impor-
tant determinant of malignant cellular behavior and is a
promising target for therapeutic intervention.
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Figure W1. Tiam1 expression in the orthotopical cecum of mouse, by immunohistochemical method. If positive signals were present, the cytoplasm stained brown.
For negative controls, the antibody was replaced by PBS. The results showed that Tiam1 was positive in Mock tumor (A) and was weak positive in Tiam1KD/
clone 2 tumor (B).
